John Buse

105PUBLICATIONS
273CO-AUTHORS
Predictive and prognostic markersFood properties (incl. characteristics and health benefits)Medical roboticsInfant and child healthSport and exercise nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (105)

|Jun 02, 2026
GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women.

|May 30, 2026
Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey.

|Mar 26, 2026
Towards intelligent and miniaturized drug delivery devices.

Xinwei Wei, John B Buse, Hongming Chen

|Dec 18, 2025
The Effect of COVID-19 on Incident Diabetes in Pediatric Patients: Findings From the National COVID-19 Cohort Collaborative (N3C).

Rachel Wong, Talia Wiggen, Margaret A Hall

|Nov 14, 2025
Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care.

Naveed Sattar, John B Buse

|Oct 15, 2025
Long-term comparative effectiveness of once-weekly semaglutide versus alternative treatments in a real-world US adult population with type 2 diabetes: a randomized pragmatic clinical trial.

John B Buse, Helene Nordahl Christensen, Brian J Harty

Pageof 18

Frequent Collaborators

18 joint publications

Steven E Kahn

15 joint publications

Elizabeth Selvin

12 joint publications

Til Stürmer

8 joint publications

Vanita R Aroda